Bottom line
RYHCX vs JDOC: the short answer
RYHCX (Health Care Fund) and JDOC (JPMorgan Healthcare Leaders ETF) are both mutual funds.
But RYHCX is far broader, holding 135 positions to 61 for JDOC, so beyond the top names it adds exposure JDOC doesn't have.
JDOC is cheaper at 0.65% vs 2.4% — a difference of $175 a year per $10,000 invested.
Over one year, JDOC returned +14.9% vs +12.3% for RYHCX.
Updated Nov 19, 2026
RYHCX vs JDOC side by side
| RYHCX | JDOC | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Guggenheim | J.P. Morgan |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 2.4% | 0.65% |
| Annual cost per $10k | $240 | $65 |
| 10-yr cost on $10k (prospectus) | $2,782 | $810 |
| Max front load | 0% | None |
| 12b-1 fee | 1% | — |
| 1-yr return | +12.3% | +14.9% |
| 5-yr return (annualized) | +4.1% | — |
| 10-yr return (annualized) | +6.8% | — |
| Best quarter | +18.4% | +11.3% |
| Worst quarter | −14.6% | −11.9% |
| Net assets (fund) | $19.4M | $9.1M |
| Number of holdings | 135 | 61 |
| Portfolio turnover | 244% | 92% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | RYHCX | JDOC | Difference |
|---|---|---|---|
| 2025 | +13.3% | +14.9% | −1.6% |
| 2024 | −0.4% | −0.6% | +0.2% |
Source: Fund prospectus bar charts
Holdings overlap
15 of RYHCX's top 25 holdings also appear in JDOC's top 25.
| Holding | RYHCX | JDOC |
|---|---|---|
| Eli Lilly & Company | 3.63% | 7.76% |
| Johnson & Johnson | 2.88% | 4.82% |
| Abbvie Inc | 2.52% | 7.85% |
| Unitedhealth Group Inc | 2.22% | 5.85% |
| Merck & Company Inc | 2.04% | 4.82% |
| Thermo Fisher Scientific Inc | 1.61% | 3.73% |
| Abbott Laboratories | 1.42% | 3.11% |
| Cvs Health Corp | 1.31% | 2.83% |
| Intuitive Surgical Inc | 1.31% | 1.93% |
| Danaher Corp | 1.30% | 2.16% |
| Bristol-myers Squibb Company | 1.22% | 3.57% |
| Stryker Corp | 1.21% | 2.23% |
| Regeneron Pharmaceuticals Inc | 0.90% | 1.60% |
| Cardinal Health Inc | 0.86% | 1.51% |
| Edwards Lifesciences Corp | 0.84% | 1.73% |
Source: SEC Form N-PORT
RYHCX top 10
- Eli Lilly & Company — 3.63%
- Johnson & Johnson — 2.88%
- Abbvie Inc — 2.52%
- Unitedhealth Group Inc — 2.22%
- Merck & Company Inc — 2.04%
- Thermo Fisher Scientific Inc — 1.61%
- Amgen Inc — 1.56%
- Abbott Laboratories — 1.42%
- Gilead Sciences Inc — 1.39%
- Vertex Pharmaceuticals Inc — 1.34%
JDOC top 10
- AbbVie, Inc. — 7.85%
- Eli Lilly & Co. — 7.76%
- UnitedHealth Group, Inc. — 5.85%
- Merck & Co., Inc. — 4.82%
- Johnson & Johnson — 4.82%
- AstraZeneca plc — 3.76%
- Thermo Fisher Scientific, Inc. — 3.73%
- Bristol-Myers Squibb Co. — 3.57%
- Abbott Laboratories — 3.11%
- CVS Health Corp. — 2.83%
FAQ
What is the difference between RYHCX and JDOC?
Which is cheaper, RYHCX or JDOC?
Should I own both RYHCX and JDOC?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.